What is FeLV and FIV?
Feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) infections are two of the most common and fatal feline diseases worldwide. Infections can cause severe immune suppression, anemia, and result in increased risk of other infections. LTCI is the first and only approved treatment aid* in the United States for cats suffering from FeLV and FIV infections.
I've read that FeLV / FIV is not treatable?
LTCI is new to the market as a treatment aid for feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) infections. As with any new product on the market, it will take time for the new product information to be distributed to animal health organizations and pet owners and the information to be updated in literature and websites.
How does LTCI work?
LTCI is a naturally occurring immune stimulating protein that helps restore your cat's ability to fight infection by increasing the production of lymphocytes.
What are Lymphocytes?
Lymphocytes are immune cells that help the body identify and destroy viruses and certain cancers.
How is LTCI administered and how often?
LTCI is injected under the skin. For the first month LTCI is given weekly, then it can usually be given monthly, or as needed, depending on the cat's response and your veterinarian's advice.
When should my sick cat feel better?
Clinical studies show that some cats respond in the first few weeks. Response to treatment may vary depending on your cat's condition and their immune status.
How safe is LTCI?
LTCI has passed a formal safety study where no significant adverse events were reported.
Is LTCI natural?
Yes, LTCI is a naturally occurring treatment aid and is not synthetically made.
Where can I get LTCI?
LTCI is only available through licensed veterinarians in the United States. Please contact your veterinarian to discuss LTCI treatment options.
Technical Services:
Call our toll free technical services number (877) 892-9595, or you can email us your technical questions.
*Lymphocyte T-Cell Immunomodulator has received a conditional license from the United States Department of Agriculture. Additional efficacy and potency studies are in progress. LTCI is manufactured by T-Cyte Therapeutics, Inc. and is exclusively distributed by IMULAN BioTherapeutics, LLC.
